bromodeoxyuridine has been researched along with kh 1060 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clausen, OP; De Angelis, P; Grøsvik, H; Lützow-Holm, C | 1 |
| Clausen, OP; De Angelis, P; Lützow-Holm, C | 1 |
| Binderup, L; Gumireddy, K; Ikegaki, N; Phillips, PC; Reddy, CD; Reddy, GS; Sutton, LN | 1 |
3 other study(ies) available for bromodeoxyuridine and kh 1060
| Article | Year |
|---|---|
1,25-Dihydroxyvitamin D3 and the vitamin D analogue KH1060 induce hyperproliferation in normal mouse epidermis. A BrdUrd/DNA flow cytometric study.
Topics: Animals; Bromodeoxyuridine; Calcitriol; Calcium; Cell Cycle; Cell Division; DNA; Epidermis; Flow Cytometry; Hyperplasia; Mice; Mice, Hairless | 1993 |
Calcitriol and its analog KH 1060 induce similar changes in keratinocyte cell cycle progression after topical application to mouse skin. A bromodeoxyuridine pulse-chase flow cytometric study.
Topics: Administration, Topical; Animals; Bromodeoxyuridine; Calcitriol; Cell Cycle; Flow Cytometry; Keratinocytes; Male; Mice; Mice, Hairless; Mice, Inbred C3H; S Phase | 1996 |
Anti-proliferative effects of 20-epi-vitamin-D3 analogue, KH1060 in human neuroblastoma: induction of RAR-beta and p21(Cip1).
Topics: Antineoplastic Agents; Blotting, Western; Brain Neoplasms; Bromodeoxyuridine; Calcitriol; Caspase 3; Caspases; Cell Division; Cell Survival; Cholecalciferol; Coloring Agents; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Humans; Inhibitory Concentration 50; Models, Chemical; Neuroblastoma; Proto-Oncogene Proteins c-myc; Receptors, Retinoic Acid; Reverse Transcriptase Polymerase Chain Reaction; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2003 |